Inman R S, Coughlan M M, Wessling-Resnick M
Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts 02115.
Biochemistry. 1994 Oct 4;33(39):11850-7. doi: 10.1021/bi00205a022.
The reduction of Fe3+ to Fe2+ has been established to play a critical role in the uptake of iron by many organisms. Recently, a mechanism of iron transport in the absence of transferrin (Tf) was described for the human K562 cell line and a role for ferrireductase activity was implicated in this process as well [Inman, R. S., & Wessling-Resnick, M. (1993) J. Biol. Chem. 268, 8521-8528]. The present report characterizes the extracellular reduction of ferricyanide to ferrocyanide catalyzed by K562 cells. The observation that membrane-impermeant ferricyanide competitively inhibits Tf-independent assimilation of iron from 55Fe-nitriloacetic acid indicates that this ferrireductase activity is indeed coupled to the transport mechanism. From a series of initial rate experiments, the kinetic parameters for cell surface ferrireductase activity, Vmax = 0.102 nmol min-1 (10(6) cells)-1 and Km = 6.13 microM, were determined. Neither the Vmax nor the Km of this reaction is modulated by changes in extra- or intracellular iron levels; thus, similar to Tf-independent transport activity in K562 cells, the ferrireductase activity is not regulated in response to iron levels. Transmembrane oxidoreductase activity is also reportedly involved in the control of cellular growth; however, the K562 cell ferrireductase is unresponsive to insulin and is not inhibited by the antitumor drugs adriamycin, actinomycin D, or cis-platin, observations that fail to support a role for this particular activity in cell regulation. Rather, the K562 cell ferrireductase appears to be tightly coupled to the mechanism of Tf-independent transport as demonstrated by its sensitivity to Cd2+, a specific inhibitor of non-Tf iron uptake by K562 cells.(ABSTRACT TRUNCATED AT 250 WORDS)
Fe3+还原为Fe2+已被证实对许多生物体吸收铁起着关键作用。最近,有人描述了人K562细胞系在无转铁蛋白(Tf)情况下的铁转运机制,并且在此过程中也涉及到了铁还原酶活性的作用[英曼,R.S.,&韦斯林-雷斯尼克,M.(1993年)《生物化学杂志》268,8521 - 8528]。本报告描述了K562细胞催化铁氰化物细胞外还原为亚铁氰化物的特性。膜不透性铁氰化物竞争性抑制从55Fe - 次氮基三乙酸中独立于Tf的铁同化这一观察结果表明,这种铁还原酶活性确实与转运机制相关联。通过一系列初始速率实验,确定了细胞表面铁还原酶活性的动力学参数,Vmax = 0.102 nmol min-1(10(6)个细胞)-1,Km = 6.13 microM。该反应的Vmax和Km均不受细胞外或细胞内铁水平变化的调节;因此,与K562细胞中独立于Tf的转运活性类似,铁还原酶活性不受铁水平的调节。据报道,跨膜氧化还原酶活性也参与细胞生长的控制;然而,K562细胞铁还原酶对胰岛素无反应,且不受抗肿瘤药物阿霉素、放线菌素D或顺铂的抑制,这些观察结果不支持这种特定活性在细胞调节中起作用。相反,K562细胞铁还原酶似乎与独立于Tf的转运机制紧密相关,这一点通过其对Cd2+(K562细胞非Tf铁摄取的特异性抑制剂)的敏感性得到证明。(摘要截短至250字)